Press releases | WebDisclosure

Basculer en Français

9808	Companies
196797	Keywords
127793	Articles
104621	Press releases

Home
Press releases

PRESS RELEASE

published on 03/13/2025 at 14:20, 10 months 23 days ago

Storm Exploration Grants Stock Options
Storm Exploration Inc. grants 1,860,000 stock options at $0.07 per share to directors, officers, and consultants, subject to TSX Venture Exchange approval

Stock Options TSX Venture Exchange Mineral Exploration Storm Exploration Inc. Canadian Company
PRESS RELEASE

published on 03/13/2025 at 14:01, 10 months 23 days ago

Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer
Mainz Biomed and Liquid Biosciences make groundbreaking discovery of mRNA biomarkers for blood-based detection of pancreatic cancer, achieving transformative sensitivity of 95% and specificity of 98%

Mainz Biomed MRNA Biomarkers Pancreatic Cancer Liquid Biosciences Blood-based Detection
PRESS RELEASE

published on 03/13/2025 at 14:01, 10 months 23 days ago

Healthcare Specialist SHS Capital, together with its co-investors, sells Selfapy GmbH to MEDICE - The Health Family
SHS Capital and co-investors sell Selfapy GmbH to MEDICE - The Health Family, a step towards clinically validated healthcare solutions integrating pharmaceuticals and digital concepts

Healthcare Solutions Digital Health SHS Capital Selfapy GmbH MEDICE
PRESS RELEASE

published on 03/13/2025 at 14:00, 10 months 23 days ago

Amoéba participe à la 3ème édition du Retail Day organisée par Euroland Corporate et Bourse Direct le jeudi 20 mars 2025
Amoéba, greentech spécialisée dans les solutions microbiologiques naturelles, participe à la 3ème édition du Retail Day pour présenter sa vision et stratégie de développement

AMOEBA Développement GreenTech Retail Day Solutions Microbiologiques
PRESS RELEASE

published on 03/13/2025 at 14:00, 10 months 23 days ago

Vox Royalty Provides Development Updates and Approval of 2025 Share Repurchase Program
Vox Royalty Corp. provides updates on mining royalty partners Black Cat Syndicate Limited, Orla Mining Ltd., and Galway Metals Inc. Recent developments include new acquisitions and progress towards production in Western Australia, Nevada, and Quebec

Acquisitions Vox Royalty Corp. Production Mining Royalty Partners
PRESS RELEASE

published on 03/13/2025 at 13:45, 10 months 23 days ago

bonyf recently secures its EU Patent, US patent pending, for PerioTabs® & PerioCream, launch in March 2025 at the IDS Cologne
bonyf secures EU Patent, pending US patent, for PerioTabs® & PerioCream, set to launch at IDS Cologne in March 2025. Products aim to revolutionize dental care practices globally

Bonyf PerioTabs EU Patent PerioCream IDS Cologne
PRESS RELEASE

published on 03/13/2025 at 13:41, 10 months 23 days ago

Form 8.3 - Equals Group PLC
Chelverton Asset Management discloses a 1.18% stake in Equals Group PLC. No other disclosures made

Stake Chelverton Asset Management Equals Group PLC Disclosures 1.18%
PRESS RELEASE

published on 03/13/2025 at 13:38, 10 months 23 days ago

REPLY: The Board of Directors approved the draft financial statements for the year 2024
Reply S.p.A. Board of Directors approves draft financial statements for 2024, proposing dividend distribution of €1.15 per share. Positive financial indicators with increased turnover and net profit

Board Of Directors Financial Statements Dividend Distribution Reply S.p.A. Positive Indicators
PRESS RELEASE

published on 03/13/2025 at 13:30, 10 months 23 days ago

Xenetic Biosciences, Inc. Presents Positive Preclinical Data Underscoring the Potential of DNase I as an Adjunctive Treatment to Enhance Immunotherapeutic Responses
Xenetic Biosciences presents promising findings on combining DNase I with CAR T cells to enhance cancer treatment strategies at the SITC Spring Scientific 2025 Cell Therapy Meeting

Xenetic Biosciences Cancer Treatment DNase I CAR T Cells SITC Spring Meeting
PRESS RELEASE

published on 03/13/2025 at 13:30, 10 months 23 days ago

Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform
Aspire Biopharma Holdings, Inc. provides update on patent applications for Oral Mucosal Formulations of Aspirin with rapid absorption technology. Company aims to revolutionize drug delivery and improve patient outcomes

Drug Delivery Technology Patent Applications Aspire Biopharma Oral Mucosal Formulations Aspirin

Accesswire

Published on 02/05/2026 at 14:30, just now

Electrovaya Announces Date for Q1-2026 Financial Results & Conference Call
Published on 02/05/2026 at 14:00, 30 minutes ago

Organto Foods Inc. Expects Strong 2026 Growth Driven by Retail Wins and Expanded Supply Partnerships
Published on 02/05/2026 at 14:00, 30 minutes ago

Tectonic Metals Drills 272 Metres of 0.50 g/t Au and 277 Metres of 0.49 g/t Au; Confirms Bulk-Tonnage Potential at Heap-Leachable Chicken Mountain, Flat Gold Project, Alaska
Published on 02/05/2026 at 13:30, 1 hour ago

Nextech3D.ai to Report Q3 2025 Earnings After Market Close on February 18, 2026
Published on 02/05/2026 at 13:30, 1 hour ago

ESGold Expands Montauban Land Position Following 3D Geological Model Identifying Potential District-Scale Mineralized Corridor

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 14:10, 20 minutes ago

Ocean Tomo Bolsters Radio Frequency, Wireless, and Spectrum Expertise with Addition of Director Dan Sleeter
Published on 02/05/2026 at 14:00, 30 minutes ago

Gurit Expands U.S. Operations to Support Growing Subsea Demand
Published on 02/05/2026 at 13:30, 1 hour ago

Ascory Bank ends its year of transformation in 2025 with positive results and starts 2026 with a new strategy and a new name
Published on 02/05/2026 at 13:04, 1 hour 26 minutes ago

EQS-Adhoc: Ascory Bank AG raises earnings forecast for financial year 2025
Published on 02/05/2026 at 12:48, 1 hour 41 minutes ago

Turkiye Garanti Bankasi A.S.: Announcement regarding forward looking statements on the expectations for the year 2026

Les Echos

Published on 02/05/2026 at 11:30, 3 hours ago

Déclaration nombre d'actions et droits de vote - 05.02.2026
Published on 02/05/2026 at 11:30, 3 hours ago

Disclosure of shares outstanding and voting rights - 05.02.2026
Published on 02/04/2026 at 18:04, 20 hours 26 minutes ago

Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 20 hours 26 minutes ago

Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 20 hours 45 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31

View all LES ECHOS COMFI WIRE